Mark Kindy to Humans
This is a "connection" page, showing publications Mark Kindy has written about Humans.
Connection Strength
0.393
-
Effects of GrandFusion Diet on Cognitive Impairment in Transgenic Mouse Model of Alzheimer's Disease. Nutrients. 2020 Dec 30; 13(1).
Score: 0.028
-
GM6 Attenuates Alzheimer's Disease Pathology in APP Mice. Mol Neurobiol. 2019 Sep; 56(9):6386-6396.
Score: 0.024
-
Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy. J Neuroinflammation. 2018 Sep 24; 15(1):277.
Score: 0.024
-
Preface. Turk J Med Sci. 2015; 45(5):i-ii.
Score: 0.018
-
Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A?PP containing the wild-type ?-secretase site sequence. J Alzheimers Dis. 2012; 29(4):827-40.
Score: 0.015
-
Transcranial laser therapy attenuates amyloid-? peptide neuropathology in amyloid-? protein precursor transgenic mice. J Alzheimers Dis. 2011; 23(3):521-35.
Score: 0.014
-
Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis. 2011; 25(2):295-307.
Score: 0.014
-
Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease. Biol Chem. 2010 Aug; 391(8):861-72.
Score: 0.014
-
The impact of methylmercury on 1,25-dihydroxyvitamin D3-induced transcriptomic responses in dolphin skin cells. Biol Chem. 2010 Feb-Mar; 391(2-3):245-258.
Score: 0.013
-
Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol. 2008 May; 172(5):1342-54.
Score: 0.012
-
Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007 Sep; 388(9):979-83.
Score: 0.011
-
Neprilysin protects neurons against Abeta peptide toxicity. Brain Res. 2007 Jun 04; 1152:191-200.
Score: 0.011
-
Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab. 2004 Jan; 24(1):114-23.
Score: 0.009
-
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders. Pharmacol Rev. 2022 07; 74(3):600-629.
Score: 0.008
-
Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models. Nutrients. 2020 Aug 15; 12(8).
Score: 0.007
-
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med. 2000 Jun; 6(6):643-51.
Score: 0.007
-
CBF regulation in hypertension and Alzheimer's disease. Clin Exp Hypertens. 2020 Oct 02; 42(7):622-639.
Score: 0.007
-
Oxidized high-density lipoprotein induces neuron death. Exp Neurol. 2000 Feb; 161(2):621-30.
Score: 0.007
-
Insights image for vitamin D binding protein polymorphisms significantly impact vitamin D status in children. Pediatr Res. 2019 11; 86(5):674.
Score: 0.006
-
Vitamin D binding protein polymorphisms significantly impact vitamin D status in children. Pediatr Res. 2019 11; 86(5):662-669.
Score: 0.006
-
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes. PLoS One. 2018; 13(9):e0203460.
Score: 0.006
-
Commentary: Addressing Racial Disparities in Stroke: The Wide Spectrum Investigation of Stroke Outcome Disparities on Multiple Levels (WISSDOM). Ethn Dis. 2018; 28(1):61-68.
Score: 0.006
-
Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms. Prog Neurobiol. 2018 Jun - Aug; 165-167:26-50.
Score: 0.006
-
Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers. J Alzheimers Dis. 2018; 62(1):39-60.
Score: 0.006
-
Albumin-Assisted Method Allows Assessment of Release of Hydrophobic Drugs From Nanocarriers. Biotechnol J. 2018 Jan; 13(1).
Score: 0.006
-
The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2). Mol Immunol. 2017 01; 81:59-66.
Score: 0.005
-
Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics. 1996 May 15; 34(1):139-42.
Score: 0.005
-
Non-genomic oestrogen receptor signal in B lymphocytes: An approach towards therapeutic interventions for infection, autoimmunity and cancer. Int J Biochem Cell Biol. 2016 07; 76:115-8.
Score: 0.005
-
SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY. J Biol Chem. 2016 Jan 22; 291(4):1957-1973.
Score: 0.005
-
Estrogen receptor signal in regulation of B cell activation during diverse immune responses. Int J Biochem Cell Biol. 2015 Nov; 68:42-7.
Score: 0.005
-
3D printing facilitated scaffold-free tissue unit fabrication. Biofabrication. 2014 Jun; 6(2):024111.
Score: 0.004
-
Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury. J Biol Chem. 2014 May 09; 289(19):13142-54.
Score: 0.004
-
Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis? J Neurotrauma. 2014 Feb 01; 31(3):215-27.
Score: 0.004
-
Brain pyroglutamate amyloid-? is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J Alzheimers Dis. 2014; 41(1):129-49.
Score: 0.004
-
Vitamin D3 supplementation, low-risk prostate cancer, and health disparities. J Steroid Biochem Mol Biol. 2013 Jul; 136:233-7.
Score: 0.004
-
Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white men. Am J Clin Nutr. 2012 Aug; 96(2):332-6.
Score: 0.004
-
Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul; 97(7):2315-24.
Score: 0.004
-
Spinal cord infarction associated with subarachnoid hemorrhage. Clin Neurol Neurosurg. 2012 Sep; 114(7):1030-2.
Score: 0.004
-
Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease. Biochim Biophys Acta. 2012 Jan; 1824(1):89-104.
Score: 0.004
-
Decompressive craniectomy: technical note. Acta Neurol Scand. 2011 Apr; 123(4):239-44.
Score: 0.004
-
Targets for AD treatment: conflicting messages from ?-secretase inhibitors. J Neurochem. 2011 May; 117(3):359-74.
Score: 0.004
-
Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun. 2009 Aug 21; 386(2):284-8.
Score: 0.003
-
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A. 2009 Jan 27; 106(4):1285-90.
Score: 0.003
-
Semi-allogeneic vaccines and tumor-induced immune tolerance. J Transl Med. 2009 Jan 08; 7:3.
Score: 0.003
-
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008 Mar 21; 283(12):7745-53.
Score: 0.003
-
Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet. 2005 Feb 01; 14(3):447-60.
Score: 0.002
-
Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets. 2004 Aug; 5(6):517-28.
Score: 0.002
-
In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system. Nucleic Acids Res. 2003 Nov 15; 31(22):6428-34.
Score: 0.002
-
RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003 Jul; 9(7):907-13.
Score: 0.002
-
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003 Mar 15; 23(6):1992-6.
Score: 0.002
-
Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice. J Lipid Res. 2002 Sep; 43(9):1421-8.
Score: 0.002
-
Abeta deposition is essential to AD neuropathology. J Alzheimers Dis. 2002 Jun; 4(3):133-8.
Score: 0.002
-
Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J Alzheimers Dis. 2002 Jun; 4(3):145-54.
Score: 0.002
-
Key signaling pathways regulate the biological activities and accumulation of amyloid-beta. Neurobiol Aging. 2001 Nov-Dec; 22(6):967-73.
Score: 0.002
-
Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic Biol Med. 2001 Jul 01; 31(1):73-81.
Score: 0.002
-
Differences in functional magnetic resonance imaging activation by category in a visual confrontation naming task. J Neuroimaging. 2001 Apr; 11(2):165-70.
Score: 0.002
-
ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury. J Cereb Blood Flow Metab. 2000 Mar; 20(3):463-8.
Score: 0.002
-
Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology. 1999 Oct 22; 53(7):1391-6.
Score: 0.002
-
Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci. 1998 Jan 15; 18(2):687-97.
Score: 0.001
-
Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice. J Lipid Res. 1997 Aug; 38(8):1583-90.
Score: 0.001
-
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun. 1996 Sep 24; 226(3):672-80.
Score: 0.001
-
Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res. 1995 May; 36(5):1058-65.
Score: 0.001
-
Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res. 1995 Mar; 36(3):526-34.
Score: 0.001